Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
11/2001
11/13/2001US6316482 Benzamide derivatives having a vasopressin antagonistic activity
11/13/2001US6316474 Treatment of pain, schizophrenia, parkinson's disease, stroke and depression
11/13/2001US6316437 Spirohydantoin compounds and uses thereof
11/13/2001US6316020 For therapy of gastric acid related diseases in mammals
11/08/2001WO2001083473A1 Process for producing optically active sulfoxide derivative
11/08/2001WO2001083462A1 Novel, slow-acting betamimetics, a method for their production and their use as medicaments
11/08/2001WO2001083457A2 Benzimidazole-2-carbamates and their use in cancer treatment
11/08/2001WO2001083427A1 PPARη MODULATORS
11/08/2001WO2001030765A3 Method for producing therapeutic agents for ulcers
11/08/2001WO2001002340B1 Novel aminoindanes
11/08/2001US20010039290 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor from cells
11/08/2001CA2407587A1 Ppar.gamma. modulators
11/08/2001CA2405745A1 New betamimetics having a long-lasting activity, processes for preparingthem and their use as medicaments
11/07/2001EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/07/2001CN1321145A Diphenyl compounds substd. by camphor or hydantoin derivs. as sunscreen compositions
11/06/2001US6313173 Glyoxylic acid amides
11/06/2001US6313117 Succinate derivative compounds useful as cysteine protease inhibitors
11/06/2001US6312723 Compounds used in inhibiting gastric acid secretion 6-methoxy-2-(((4-methoxy-3, 5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole in tablet or capsule form with cyclodextrin
11/06/2001US6312712 Benzimidazole and cyclodextrin for gastric acid related diseases
11/06/2001CA1341314C Derivatives of benzimidazole, benzothiazole and benzoxazole
10/2001
10/31/2001EP1149072A1 Sulfonamide hydroxamates
10/31/2001EP1149069A1 Phenylglycine derivatives
10/31/2001EP0876356B1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
10/30/2001US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001US6310082 Benzimidazole compounds
10/30/2001US6310080 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/25/2001WO2001079172A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
10/25/2001WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001WO2001025238A3 Heterocyclic compounds useful as inhibitors of tyrosine kinases
10/25/2001US20010034444 Treating schizophrenia, depression, and Parkinson's disease; side effect reduction
10/24/2001EP1147091A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/24/2001EP1147079A2 Beta-phenylalanine derivatives as integrin antagonists
10/24/2001EP1045843A4 Inhibitors of farnesyl-protein transferase
10/24/2001CN1319094A Imidazolyl derivatives
10/24/2001CN1318535A Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
10/23/2001US6307043 For treatment or prophylaxis of herpes viral infections
10/23/2001US6306877 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
10/23/2001US6306873 Substituted β-thiocarboxylic acids
10/23/2001CA2083179C Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
10/23/2001CA2047496C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
10/18/2001WO2001077083A1 Process for preparing substituted benzimidazole compounds
10/18/2001US20010031788 Anticancer agents, osteoporosis, arteriosclerosis, restnosis,vision defects
10/17/2001EP1144485A1 Method for production of polyelectrolyte membranes and fuel cell
10/17/2001EP1144387A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
10/17/2001EP1144386A1 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
10/17/2001EP1144385A1 Benzoheterocycles and their use as mek inhibitors
10/17/2001EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001EP1143959A2 Antifungal activity of dicationic molecules
10/17/2001EP0776201B1 Treating anxiety
10/17/2001CN1317965A Compounds having IgE affecting properties
10/17/2001CN1073081C Naphthol derivatives and process for producing same
10/16/2001US6303633 Heteroaryl amines as novel acetylcholinesterase inhibitors
10/16/2001US6303600 Substituted azabicyclic compounds
10/16/2001CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase
10/11/2001WO2001074796A1 SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
10/11/2001WO2001074786A1 Heterobiarylsulphonamides and their use as pde 7 inhibitors
10/11/2001WO2001074743A1 Novel late transition metal catalyst complexes and oligomers therefrom
10/11/2001WO2001074506A1 Extrusion die
10/11/2001WO2001034572A3 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors
10/11/2001CA2404314A1 Succinoylamino heterocycles as inhibitors of a.beta. protein production
10/11/2001CA2404017A1 Novel late transition metal catalyst complexes and oligomers therefrom
10/10/2001EP1142880A1 Benzimidazole derivatives
10/10/2001EP1142860A1 Intermediates and process for producing fluorine-containing amino acid compound by using the same
10/10/2001EP1140859A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/10/2001EP1140856A1 Fluorescent dyes for solid phase and solution phase screening
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/10/2001EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
10/10/2001EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
10/10/2001EP1140078A2 Benzimidazole vascular damaging agents
10/10/2001EP0832065B1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
10/10/2001EP0765320B1 Benzimidazolone derivatives with central dopaminergic activity
10/10/2001CN1316998A Thiobenzimidazole derivatives
10/10/2001CN1072669C Benzimidazole compounds and their use as modulators of the GABAA receptor complex
10/09/2001US6300335 Urogenital disorders
10/09/2001US6300325 Heterocyclic receptor antagonist
10/04/2001WO2001072715A2 N-halamine vinyl compounds and their polymeric biocides
10/04/2001EP1138674A1 Crystalline forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide
10/04/2001EP1137640A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
10/04/2001EP0865433B1 Method of reducing the amount of by-products in carbendazim by adding diazotization agents
10/04/2001EP0688314B1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use
10/04/2001CA2404255A1 N-halamine vinyl compounds and their polymeric biocides
10/02/2001US6297284 Aza-enediyne, aza-enyne allene, or an aza-diallene cationic compounds that bind to nucleic acids.
10/02/2001US6297239 Inhibitors of prenyl-protein transferase
09/2001
09/27/2001WO2001070720A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
09/27/2001WO2001070705A1 2-acylaminobenzimidazole derivatives for treating glaucoma
09/27/2001WO2001070682A2 Carbocyclic side chain containing metalloprotease inhibitors
09/27/2001WO2001070217A1 Dna-cleaving antitumor agents
09/27/2001US20010024833 Reacting resin-bound 1,2-arylenediamine, 2-aminophenol, 2-aminothiophenol, or derivative with cyanogen bromide or aldehyde in the presence of oxidant
09/27/2001CA2404236A1 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
09/27/2001CA2403778A1 Carbocyclic side chain containing metalloprotease inhibitors
09/26/2001EP1135377A1 Novel compounds
09/26/2001EP1135374A1 Benzimidazole compounds that are vitronectin receptor antagonists
09/26/2001EP1135134A1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
09/26/2001EP0934252B1 Amide derivatives and their use as pesticides
09/26/2001CN1314350A Process for preparing benzimidazole-5,6-dimethyl acid
09/26/2001CN1071568C Anti-sunlight cosmetic composition with system for filtering ultraviolet rays and use of same
09/25/2001US6294580 For therapy and prophylaxis of type ii or non-insulin dependent diabetes mellitus, hyperglycaemia, dyslipidemia, type ii diabetes, type i diabetes, hypertriglyceridemia, syndrome x, insulin resistance, heart failure
09/20/2001WO2001068652A1 Condensed imidazoles as histamine h3 receptor ligands
09/20/2001WO2001068651A1 Condensed imidazoles as histamine h3 receptor ligands
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 154